In this study, we examined the effect of propofol alone and its combinatory effect with BCR-ABL TKIs in CML cell lines, primary CD34 progenitor cells and xenograft mouse model. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.